HIV
and AIDS Top News Articles |
|
 Early
Antiretroviral Therapy May Protect against HIV-related
Brain Dysfunction
7-03-2009 |
 Long-term
Testosterone Therapy Is Safe and Improves
Body Composition in Women with HIV
7-03-2009 |
 Many
HIV Positive People in the U.S. Are Not Tested
until Late Stages of Disease
7-03-2009 |
 DHHS
Issues Proposed Regulations to Remove Ban on HIV Positive
Visitors and Immigrants
7-03-2009 |
 Newer
Anti-HIV Drugs and How to
Use Them: Part 2
6-26-2009 |
 Saturday,
June 27, is National HIV Testing Day
6-26-2009 |
 Epzicom
versus Truvada in Combination with Lopinavir/ritonavir (Kaletra): Results
from the HEAT Trial
6-26-2009 |
 National
HIV/AIDS Atlas Maps the U.S. Epidemic
6-26-2009 |
 The
5th International AIDS Society Conference (AIDS 2009)
Will Take place July 19-22, 2009 in Cape Town, South Africa
6-23-2009 |
Newer
Anti-HIV Drugs and How to Use Them: Part I
6-23-2009 |
 Alcohol
Consumption May Impair Response to HAART and Increase Risk of Liver
Toxicity
6-23-2009 |
 FDA
Approves Didanosine (Videx) Label Changes
Including Dosage Adjustments and Ribavirin Interaction Warning
6-23-2009 |
 HIV
Medical Association Supports Public Health Plan Option
6-23-2009 |
Amphotericin
B Alone or with Fluconazole (Diflucan) for Treatment of HIV-related
Cryptococcal Meningitis
6-19-2009 |
Simplification
of HAART to a Single-tablet Regimen of Efavirenz, Emtricitabine,
and Tenofovir (Atripla)
6-19-2009 |
Protease
Inhibitor Monotherapy using Lopinavir/ritonavir (Kaletra)
or Boosted Atazanavir (Reyataz) Maintains Viral Suppression
6-19-2009 |
 Green
Tea Compound in a Microbicide May Help Prevent HIV Entry into Cells
6-19-2009 |
 TB
Alliance and Tibotec Form Collaboration to Develop New
Drugs for Tuberculosis
6-19-2009 |
 Mortality
and Causes of Death among Women with HIV in
the U.S.: A 10-Year Study
6-16-2009 |
 Studies
Show Tenofovir (Viread) Is Linked with Impaired
Kidney Function
6-16-2009 |
Safety
Monitoring Board Says Phase 3 Trial of Experimental NRTI
Apricitabine Can Go Forward Using Lower Dose
6-16-2009 |
 New
Research Directions for Development of an HIV vaccine
6-16-2009 |
 World
Health Organization Declares H1N1 Influenza
Has Reached Pandemic Level
6-12-2009 |
Treatment
Strategies Using Boosted Darunavir (Prezista) and Raltegravir
(Isentress) for Highly Treatment-experienced HIV Patients
6-12-2009 |
Higher
HIV Viral Load Is Associated with Increased Risk of Kidney
Dysfunction
6-12-2009 |
 Could
a Global "Test and Treat" Program
Help End the HIV Pandemic in 50 Years?
6-12-2009
|
 CDC
Issues New Fact Sheet on Risk of Transmission
of HIV and Other Sexually Transmitted Disease via Oral Sex
6-12-2009 |
 Lower
Average Community Viral Load Reduces HIV Transmission
Risk despite Unprotected Sex and Needle-sharing
6-9-2009 |
Raltegravir
(Isentress) Found to Be Effective Substitute for Enfuvirtide
(Fuzeon)
6-9-2009 |
 Low
CD4 Count and High HIV Viral Load Increase the Risk of Non-AIDS-defining
Illnesses
6-9-2009 |
 Human
Papillomavirus (HPV) Infection Is Associated with an Increased Risk
of Contracting HIV
6-9-2009 |
Studies
Show HPV Vaccine Is Effective for Older Women
and Young Men
6-9-2009 |
 Promising
Interim Results of a Study of TMC207, a New Experimental Drug for Treatment of
Multidrug-resistant Tuberculosis (MDR-TB)
6-5-2009 |
 Ongoing
HIV Replication during Treatment Interruption Is Associated with Inflammatory
and Cardiovascular Risk Markers
6-5-2009 |
CCR5
Antagonist Maraviroc (Selzentry) Appears Safe
-- but No More Effective than Placebo -- in People with CXCR4-tropic HIV
6-5-2009 |
 Intensification
of HAART Does Not Reduce
Persistent Low Levels of HIV RNA in Stable Reservoirs of Infection
6-2-2009 |
 Early
Antiretroviral Treatment
Decreases Brain Viral Load and Central Nervous System Dysfunction in SIV-infected
Monkeys
6-2-2009 |
 Antiretroviral
Therapy Is Not Responsible
for Unexplained Liver Disease in HIV Patients
without Viral Hepatitis Coinfection
6-2-2009 |
Upcoming
Workshops and Conferences
on HIV Drug Resistance, HIV and Hepatitis Coinfection, New Drugs for Hepatitis
C, and Hepatology
6-2-2009 |
Early
Antiretroviral Therapy Reduces
Disease Progression and Death in HIV Patients with Opportunistic Infections
5-29-2009 |
HAART
Has Lowered Incidence and Improved Survival of HIV Positive People with Progressive
Multifocal Leukoencephalopathy (PML)
5-29-2009 |
 CDC
Issues Flu Treatment Guidelines and Public
Health Service Updates Antiretroviral Therapy Recommendations for Pregnant Women
with HIV
5-29-2009 |
 Advocates
Decry Drastic Cuts Proposed for California HIV/AIDS Funding
5-29-2009 |
How
Effective Are Boosted Dual Protease Inhibitor Regimens
with No Additional Drugs in Treatment-naive HIV Patients?
5/22/09 |
Antiretroviral
Therapy Is Effective against Multiple HIV-1 Subtypes
5/22/09 |
Study
Finds Nevirapine (Viramune) Suppresses Residual
HIV Viremia More than Other Antiretroviral Drugs
5/22/09 |
 New
Analysis Shows Novel Nucleoside Analog KP-1461
Demonstrates Clinical Activity against HIV
5/22/09 |
 Defensin
Genes and Viral Factors May Influence Likelihood of Mother-to-child
HIV Transmission
5/22/09 |
 International
AIDS Society Urges Political Leaders to Maintain Commitment to AIDS
Funding despite Economic Crisis
5/22/09 |
GlaxoSmithKline
Meta-analysis Does Not Show Elevated Cardiovascular Risk Associated with Use of
abacavir (Ziagen, Epzicom)
5/19/09
|
First-line
Therapy with Zidovudine/lamivudine plus Lopinavir/ritonavir
Leads to Greater Bone Loss than Nevirapine plus Lopinavir/ritonavir
5/19/09
|
 HIV
Positive Men with Prostate Cancer Have Similar Short-term Outcomes
and Respond as Well to Radiation Therapy as HIV Negative Men
5/19/09
|
 Department
of Health and Human Services Will Award $1.79 Billion
for Medications and Care for People with HIV/AIDS
5/19/09
|
 May
19 Is National Asian and Pacific Islander HIV/AIDS Awareness Day
5/19/09
|
Lopinavir/ritonavir
(Kaletra) Is Superior to Nevirapine (Viramune)
for HIV-infected Children Who Received Single-dose Nevirapine at Birth
5/15/09
|
 May
18 Is HIV Vaccine Awareness Day
5/15/09 |
Safety
of Switching from Twice-daily to Once-daily Nevirapine
(Viramune) in HIV Patients with Suppressed Viral Load and High CD4
Count
5/15/09 |
 Metabolic
and Body Shape Abnormalities Are Common in Children and
Youth with HIV
5/15/09 |
Raltegravir
(Isentress) plus Lopinavir/ritonavir (Kaletra) Produces Rapid Viral
Load Decline in Treatment-naive HIV Patients
5/08/09 |
 Natural
Hormone Leptin Improves Blood Lipid Levels and Insulin Sensitivity
and Decreases Abdominal Fat in People with HIV
5/08/09 |
Meta-analysis
Shows Very Low Risk of Heterosexual Transmission
if HIV Positive Partner is on Antiretroviral Therapy with Undetectable Viral Load
5/08/09 |
 NIH
Recommends Use of Abbott RealTime HIV Viral Load Test
for NIH-sponsored Clinical Trials
5/08/09 |
H1N1
Swine Flu Update and CDC Interim Guidance for Clinicians Treating People
with HIV
5/05/09 |
Low
CD4 Cell Count Increases the Risk of Frailty among Individuals with
HIV
5/05/09 |
 4-Year
Study Finds Polyacrylamine Hydrogel (Aquamid) Facial
Filler Is a Safe and Satisfactory Treatment for Lipoatrophy
5/05/09 |
 Studies
Yield Mixed Data Regarding Effects of HIV Infection and
Antiretroviral Therapy on Blood Vessel Function and Biomarkers
5/01/09 |
 Rationing
Antiretroviral Therapy in Africa -- Treating
Too Few, Too Late
5/01/09 |
 Obama
Names Eric Goosby as Global AIDS Coordinator
and PEPFAR Administrator
5/01/09 |
 FDA
Will Require Additional Warnings for Over-the-counter
Pain Medications, Including Acetaminophen, Aspirin, and Ibuprofen
5/01/09 |
U.S.
Declares Public Health Emergency as Swine Flu
Outbreak Spreads
4/28/09 |
 Long-term
Study Finds No Link between Maternal Use of Antiretroviral Therapy -- including
Efavirenz (Sustiva) -- and Birth Defects
4/28/09 |
 CDC
Report Looks at HIV-associated Risk Behaviors among Injection Drug
Users in 23 U.S. Cities
4/28/09 |
 Bristol-Myers
Squibb Announces Copayment Assistance Programs for Atazanavir
(Reyataz), Efavirenz (Sustiva), and Atripla
4/28/09 |
Antiretroviral
Treatment Interruption May Be a Viable Strategy if CD4 Cell Count Remains
High
4/24/09 |
Causes
and Management of Poor CD4 Cell Recovery despite
Virologically Suppressive HAART
4/24/09 |
Does
Antiretroviral Therapy Cause Long-Term Liver Damage
in HIV Positive People with and without Hepatitis C?
4/24/09 |
Raltegravir
(Isentress) Reaches High Levels in the Genital Tract of HIV Negative
Women, Suggesting Potential for Preventive Therapy
4/24/09 |
 IDSA
HIV Medicine Association and American College of Physicians Call for Universal
HIV Testing and Broader Coverage of Care
4/24/09 |
Gilead
Initiates Phase 2 Clinical Trial of Once-daily, 4-drug Combination Pill Containing
Integrase Inhibitor Elvitegravir
4/21/09 |
Virological
Suppression Reduces Disease Progression in Patients with Highly Resistant
HIV
4/21/09
|
Newly
Updated Guidelines for Prevention and Treatment of HIV-related Opportunistic
Infections
4/21/09
|
Some
AIDS-defining Opportunistic Illnesses Remain
a Significant Cause of Death in the HAART Era
4/21/09 |
What
are the Next Practical Steps to Prevent or Reduce the Rate of New
HIV Infections?
-
4/21/09
|
Some
People Do Not Achieve Complete CD4 Cell Recovery even after 10 Years on Suppressive
Antiretroviral Therapy
4/17/09 |
Suboptimal
Adherence May Have Less Detrimental Effect in Patients Taking Boosted Darunavir
(Prezista)
4/17/09 |
GlaxoSmithKline
and Pfizer Agree to Create a New HIV-focused Company
4/17/09 |
Tobira
Therapeutics Initiates Proof-of-concept Study of Experimental
CCR5 Antagonist TAK-652
4/17/09 |
 Studies
Examine Bone Loss in Women with HIV
4/17/09 |
Should
the Threshold for Starting Antiretroviral Therapy
Be Raised?
4/13/09 |
NRTI
Backbone Choice Affects Durability of Efavirenz- or Nevirapine-based
HAART in Treatment-naive HIV patients
4/13/09 |
 Protease
Inhibitor Regimens Associated with Greater Decrease in Bone
Mineral Density than NNRTI Regimens in Treatment-naive HIV Patients
4/13/09 |
 Naturally
Occurring Vaginal Microbicide Compound Protects
Monkeys against SIV Infection
4/13/09
|
AIDS
Drug Assistance Programs Feel the Effects of Recession
4/13/09 |
 Raltegravir
(Isentress) plus Lopinavir/ritonavir (Kaletra) Produces More Rapid
HIV Decline in Treatment-naive HIV Patients
4/10/09 |
Reports
from the 15th British HIV Association Meeting (BHIVA
2009)
4/10/09 |
Lopinavir/ritonavir
(Kaletra) Label Changed to Reflect Potential Risk of Heart Rhythm Abnormalities
4/10/09
|
 Durable
Effects of Polylactic Acid for Facial Lipoatrophy
in People with HIV
4/10/09 |
 White
House and U.S. Public Health Agencies Launch New 5-year
HIV/AIDS Awareness Campaign
4/10/09
|
Early
Initiation of HAART Significantly Prolongs
Survival
4/07/09 |
Non-AIDS-defining
Cancer Is an Increasingly Common Cause of Death among HIV Patients
4/07/09 |
Liver
Disease Is a Growing Cause of Death for HIV Positive People in France,
but Has Leveled Off in Spain
4/07/09 |
Many
Non-specialist Hospital Physicians Have a
Poor Understanding of Antiretroviral Therapy for HIV
4/07/09 |
 Lower
CD4 Counts in Seroconverters Suggest HIV May Have Become More Virulent
4/03/09 |
Fosamprenavir
(Lexiva) Works Well with 100 mg Ritonavir (Norvir) at 96 Weeks in Treatment-naive
Patients
4/03/09 |
 Non-Hodgkin
Lymphoma Mortality Remains High for People with HIV, but Antiretroviral
Therapy Reduces Risk
4/03/09 |
FDA
Approves Generic Versions of Abacavir/lamivudine, Tenofovir/emtricitabine, Nevirapine,
and Stavudine/lamivudine/nevirapine for PEPFAR Program
-
4/03/09 |
Congressional
Representatives Introduce Bill to Expand Medicaid Coverage
to HIV Positive People prior to AIDS Diagnosis
4/03/09 |
Antiretroviral
Therapy Interruption during Pregnancy Increases the Risk of Mother-to-child
HIV Transmission
3/31/09 |
Transfer
of HIV from Infected to Uninfected T-Cells Captured on Video for the First Time
3/31/09
|
WHO
Releases New Report on Tuberculosis and Its
Impact on People with HIV/AIDS
3/31/09
|
Preventive
Isoniazid plus HAART Lowers the Risk of Active Tuberculosis
among HIV Patients by 89%
3/31/09 |
 Together
Rx Access Prescription Savings Program Expands Eligibility Criteria
3/31/09 |
Antiretroviral
Therapy Interruption during Pregnancy Increases the Risk of
Mother-to-child HIV Transmission
3/27/09 |
Transfer
of HIV from Infected to Uninfected T-Cells Captured on Video for the
First Time
3/27/09 |
WHO
Releases New Report on Tuberculosis and Its
Impact on People with HIV/AIDS
3/27/09 |
Preventive
Isoniazid plus HAART Lowers the Risk of Active Tuberculosis
among HIV Patients by 89%
3/27/09 |
Together
Rx Access Prescription Savings Program Expands
Eligibility Criteria
3/27/09 |
Pioneer
HIV Researcher Calls for Antiretroviral Treatment
as a Strategy for Prevention
3/24/09 |
 Tenofovir
(Viread) during Pregnancy: Findings from the Antiretroviral Pregnancy
Registry
3/24/09 |
 Is
Tenofovir an Option for Prevention of mother-to-child
HIV transmission?
3/24/09 |
 Many
HIV Positive Inmates Stop Antiretroviral
Treatment after Leaving Prison
3/24/09 |
 International
AIDS Society Opposes Pope's Suggestion that
Condoms Increase the Problem of AIDS
3/24/09 |
 HIV/AIDS
Experts and Advocates Say Research Should Focus on a Cure
3/20/09 |
AIDS
Healthcare Foundation Calls for Starting HAART
below 350 Cells/mm3 Even in Resource-limited Countries
3/20/09 |
Methadone
Appears Not to Interact with HIV Protease Inhibitors
3/20/09 |
Experimental
NRTI Apricitabine Demonstrates Good Antiviral Activity with No Serious
Side Effects at 96 Weeks
3/20/09 |
| |
